Association between prenatal medication exposure and the risk of autism spectrum disorder (ASD): A review
Pharmacotherapy in Psychiatry and Neurology · 2026
DOI: 10.17219/fpn/218457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2026. Verfasst von Jakub Białek und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Białek, J., Dankowska, A., Zielonka, M., Bajkacz, A., Polakowska, I., Roszyk, A., Stygar, P., Bęben, A., Głowacka, Z., & Orczyk, K. (2026). Association between prenatal medication exposure and the risk of autism spectrum disorder (ASD): A review. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.17219/fpn/218457
Vancouver
Białek J, Dankowska A, Zielonka M, Bajkacz A, Polakowska I, Roszyk A, et al. Association between prenatal medication exposure and the risk of autism spectrum disorder (ASD): A review. Pharmacotherapy in Psychiatry and Neurology. 2026. doi:10.17219/fpn/218457
BibTeX
@article{Biaek2026,
author = {Białek, Jakub and Dankowska, Alicja and Zielonka, Magłorzata and Bajkacz, Agnieszka and Polakowska, Izabela and Roszyk, Agnieszka and Stygar, Patrycja and Bęben, Agata and Głowacka, Zuzanna and Orczyk, Kamil},
title = {Association between prenatal medication exposure and the risk of autism spectrum disorder (ASD): A review},
journal = {Pharmacotherapy in Psychiatry and Neurology},
year = {2026},
doi = {10.17219/fpn/218457}
}
EUVIMED